| Target Price | $78.54 |
| Price | $63.28 |
| Potential | 24.12% |
| Number of Estimates | 38 |
| 38 Analysts have issued a price target Nike 2027 . The average Nike target price is $78.54. This is 24.12% higher than the current stock price. The highest price target is $126.00 99.12% , the lowest is $35.35 44.14% . | |
| A rating was issued by 44 analysts: 26 Analysts recommend Nike to buy, 16 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Nike stock has an average upside potential 2027 of 24.12% . Most analysts recommend the Nike stock at Purchase. |
41 Analysts have issued a sales forecast Nike 2026 . The average Nike sales estimate is $47.2b . This is 1.45% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $49.9b 7.28% , the lowest is $45.1b 3.09% .
This results in the following potential growth metrics:
| 2025 | $46.3b | 9.84% |
|---|---|---|
| 2026 | $47.2b | 1.90% |
| 2027 | $49.4b | 4.60% |
| 2028 | $51.8b | 4.93% |
| 2029 | $55.6b | 7.43% |
| 2030 | $58.8b | 5.61% |
| 2031 | $62.2b | 5.80% |
| 2032 | $65.9b | 5.94% |
41 Nike Analysts have issued a net profit forecast 2026. The average Nike net profit estimate is $2.4b . This is 5.10% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.0b 17.97% , the lowest is $2.0b 21.43% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | $3.2b | 43.53% |
|---|---|---|
| 2026 | $2.4b | 25.59% |
| 2027 | $3.6b | 50.36% |
| 2028 | $4.4b | 21.75% |
| 2029 | $6.2b | 41.53% |
| 2030 | $7.0b | 12.50% |
| 2031 | $8.5b | 21.37% |
| 2032 | $9.4b | 11.44% |
| 2025 | 6.95% | 37.36% |
|---|---|---|
| 2026 | 5.08% | 26.92% |
| 2027 | 7.30% | 43.70% |
| 2028 | 8.47% | 16.03% |
| 2029 | 11.15% | 31.64% |
| 2030 | 11.88% | 6.55% |
| 2031 | 13.63% | 14.73% |
| 2032 | 14.34% | 5.21% |
41 Analysts have issued a Nike forecast for earnings per share. The average Nike EPS is $1.62 . This is 4.71% lower than earnings per share in the financial year 2025. The highest EPS forecast is $2.02 18.82% , the lowest is $1.34 21.18% .
This results in the following potential growth metrics and future valuations:
| 2025 | $2.16 | 42.09% |
|---|---|---|
| 2026 | $1.62 | 25.00% |
| 2027 | $2.44 | 50.62% |
| 2028 | $2.97 | 21.72% |
| 2029 | $4.20 | 41.41% |
| 2030 | $4.73 | 12.62% |
| 2031 | $5.74 | 21.35% |
| 2032 | $6.39 | 11.32% |
| Current | 37.22 | 59.28% |
|---|---|---|
| 2026 | 39.02 | 4.83% |
| 2027 | 25.95 | 33.50% |
| 2028 | 21.32 | 17.84% |
| 2029 | 15.06 | 29.36% |
| 2030 | 13.39 | 11.09% |
| 2031 | 11.03 | 17.63% |
| 2032 | 9.90 | 10.24% |
Based on analysts' sales estimates for 2026, the Nike stock is valued at an EV/Sales of 1.98 and an P/S ratio of 1.99 .
This results in the following potential growth metrics and future valuations:
| Current | 2.01 | 12.23% |
|---|---|---|
| 2026 | 1.98 | 1.58% |
| 2027 | 1.89 | 4.40% |
| 2028 | 1.80 | 4.70% |
| 2029 | 1.68 | 6.92% |
| 2030 | 1.59 | 5.31% |
| 2031 | 1.50 | 5.48% |
| 2032 | 1.42 | 5.61% |
| Current | 2.01 | 12.73% |
|---|---|---|
| 2026 | 1.99 | 1.43% |
| 2027 | 1.90 | 4.40% |
| 2028 | 1.81 | 4.70% |
| 2029 | 1.68 | 6.92% |
| 2030 | 1.59 | 5.31% |
| 2031 | 1.51 | 5.48% |
| 2032 | 1.42 | 5.61% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Guggenheim |
Buy
➜
Buy
|
Unchanged | Dec 19 2025 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Dec 19 2025 |
| Needham |
Buy
➜
Buy
|
Unchanged | Dec 19 2025 |
| Bernstein |
Outperform
➜
Outperform
|
Unchanged | Dec 19 2025 |
| Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Dec 19 2025 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Dec 19 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Dec 19 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Guggenheim:
Buy
➜
Buy
|
Dec 19 2025 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Dec 19 2025 |
|
Unchanged
Needham:
Buy
➜
Buy
|
Dec 19 2025 |
|
Unchanged
Bernstein:
Outperform
➜
Outperform
|
Dec 19 2025 |
|
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Dec 19 2025 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Dec 19 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Dec 19 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


